• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD44s 调节 TGF-β 介导的间充质表型,与肝癌患者的不良预后相关。

CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma.

机构信息

Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Honjo, Kumamoto, Japan.

出版信息

Cancer Res. 2012 Jul 1;72(13):3414-23. doi: 10.1158/0008-5472.CAN-12-0299. Epub 2012 May 2.

DOI:10.1158/0008-5472.CAN-12-0299
PMID:22552294
Abstract

The prognosis for individuals diagnosed with hepatocellular carcinoma (HCC) remains poor because of the high frequency of invasive tumor growth, intrahepatic spread, and extrahepatic metastasis. Here, we investigated the role of the standard isoform of CD44 (CD44s), a major adhesion molecule of the extracellular matrix and a cancer stem cell marker, in the TGF-β-mediated mesenchymal phenotype of HCC. We found that CD44s was the dominant form of CD44 mRNA expressed in HCC cells. Overexpression of CD44s promoted tumor invasiveness and increased the expression of vimentin, a mesenchymal marker, in HCC cells. Loss of CD44s abrogated these changes. Also in the setting of CD44s overexpression, treatment with TGF-β1 induced the mesenchymal phenotype of HCC cells, which was characterized by low E-cadherin and high vimentin expression. Loss of CD44s inhibited TGF-β-mediated vimentin expression, mesenchymal spindle-like morphology, and tumor invasiveness. Clinically, overexpression of CD44s was associated with low expression of E-cadherin, high expression of vimentin, a high percentage of phospho-Smad2-positive nuclei, and poor prognosis in HCC patients, including reduced disease-free and overall survival. Together, our findings suggest that CD44s plays a critical role in the TGF-β-mediated mesenchymal phenotype and therefore represents a potential therapeutic target for HCC.

摘要

被诊断患有肝细胞癌(HCC)的个体的预后仍然较差,因为侵袭性肿瘤生长、肝内扩散和肝外转移的频率较高。在这里,我们研究了细胞外基质的主要粘附分子和癌症干细胞标志物标准 CD44 同种型(CD44s)在 TGF-β 介导的 HCC 间充质表型中的作用。我们发现 CD44s 是 HCC 细胞中表达的 CD44 mRNA 的主要形式。CD44s 的过表达促进了肿瘤的侵袭性,并增加了 HCC 细胞中间充质标志物波形蛋白的表达。CD44s 的缺失消除了这些变化。同样在 CD44s 过表达的情况下,TGF-β1 处理诱导 HCC 细胞的间充质表型,其特征是 E-钙粘蛋白表达降低和波形蛋白表达升高。CD44s 的缺失抑制了 TGF-β 介导的波形蛋白表达、间充质纺锤形形态和肿瘤侵袭性。临床上,CD44s 的过表达与 E-钙粘蛋白表达降低、波形蛋白表达升高、磷酸化 Smad2 阳性核百分比高以及 HCC 患者预后不良相关,包括疾病无进展和总生存时间缩短。总之,我们的研究结果表明,CD44s 在 TGF-β 介导的间充质表型中起关键作用,因此代表了 HCC 的潜在治疗靶点。

相似文献

1
CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma.CD44s 调节 TGF-β 介导的间充质表型,与肝癌患者的不良预后相关。
Cancer Res. 2012 Jul 1;72(13):3414-23. doi: 10.1158/0008-5472.CAN-12-0299. Epub 2012 May 2.
2
Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition.血清反应因子在肝细胞癌中的表达:对上皮-间质转化的影响
Int J Oncol. 2007 Dec;31(6):1309-15.
3
Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.缺氧诱导肝癌细胞中β-catenin 的激活促进其转移潜能增强和预后不良。
Clin Cancer Res. 2010 May 15;16(10):2740-50. doi: 10.1158/1078-0432.CCR-09-2610. Epub 2010 May 11.
4
Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resection.骨桥蛋白和CD44s表达在接受肝移植或肝切除的肝细胞癌患者中的作用。
Transplant Proc. 2008 Nov;40(9):3182-4. doi: 10.1016/j.transproceed.2008.08.034.
5
Induction of tumor initiation is dependent on CD44s in c-Met⁺ hepatocellular carcinoma.在c-Met⁺肝细胞癌中,肿瘤起始的诱导依赖于CD44s。
BMC Cancer. 2015 Mar 21;15:161. doi: 10.1186/s12885-015-1166-4.
6
High CD44s expression is associated with the EMT expression profile and intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy.高 CD44s 表达与 EMT 表达谱有关,并与局部消融治疗后肝癌的肝内播散有关。
J Hepatobiliary Pancreat Sci. 2013 Apr;20(4):429-34. doi: 10.1007/s00534-012-0580-0.
7
Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.程序性细胞死亡4参与转化生长因子-β1诱导的人肝细胞癌细胞凋亡
Oncogene. 2006 Oct 5;25(45):6101-12. doi: 10.1038/sj.onc.1209634. Epub 2006 May 8.
8
A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.血小板衍生生长因子(PDGF)在转化生长因子-β(TGF-β)介导的肝细胞癌进展中的关键作用。
Oncogene. 2006 May 25;25(22):3170-85. doi: 10.1038/sj.onc.1209083.
9
The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.转化生长因子-β(TGF-β)的基因表达水平作为肝细胞癌的生物学预后标志物。
J Exp Clin Cancer Res. 2005 Sep;24(3):415-21.
10
TGF-beta1-promoted epithelial-to-mesenchymal transformation and cell adhesion contribute to TGF-beta1-enhanced cell migration in SMMC-7721 cells.转化生长因子β1(TGF-β1)促进的上皮-间质转化及细胞黏附有助于TGF-β1增强SMMC-7721细胞的迁移。
Cell Res. 2003 Oct;13(5):343-50. doi: 10.1038/sj.cr.7290179.

引用本文的文献

1
Cancer-Associated Fibroblasts Establish Spatially Distinct Prognostic Niches in Subcutaneous Colorectal Cancer Mouse Model.癌症相关成纤维细胞在皮下结直肠癌小鼠模型中建立空间上不同的预后生态位。
Cancers (Basel). 2025 Jul 19;17(14):2402. doi: 10.3390/cancers17142402.
2
CD44: a key regulator of iron metabolism, redox balance, and therapeutic resistance in cancer stem cells.CD44:癌症干细胞中铁代谢、氧化还原平衡及治疗抗性的关键调节因子。
Stem Cells. 2025 May 27;43(6). doi: 10.1093/stmcls/sxaf024.
3
CD44 on cancer stem cell is a potential immunological and prognostic pan-cancer biomarker.
癌症干细胞上的CD44是一种潜在的免疫和预后泛癌生物标志物。
Cancer Cell Int. 2025 Apr 8;25(1):134. doi: 10.1186/s12935-025-03748-4.
4
Transforming Growth Factor-β Modulates Cancer Stem Cell Traits on CD44 Subpopulations in Hepatocellular Carcinoma.转化生长因子-β调节肝癌中CD44亚群上的癌症干细胞特性。
J Cell Biochem. 2025 Feb;126(2):e70003. doi: 10.1002/jcb.70003.
5
HBx Facilitates Drug Resistance in Hepatocellular Carcinoma via CD133-regulated Self-renewal of Liver Cancer Stem Cells.乙肝病毒X蛋白通过CD133调控的肝癌干细胞自我更新促进肝细胞癌的耐药性。
J Clin Transl Hepatol. 2025 Jan 28;13(1):15-24. doi: 10.14218/JCTH.2024.00259. Epub 2024 Nov 25.
6
SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinoma.SLC4A11 介导氨的摄取并促进肝癌中的癌症干细胞特性。
JCI Insight. 2024 Nov 8;9(21):e184826. doi: 10.1172/jci.insight.184826.
7
TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities.转化生长因子-β(TGF-β)调节结直肠癌中的信号通路:新的潜在治疗机会。
Int J Mol Sci. 2024 Jul 5;25(13):7400. doi: 10.3390/ijms25137400.
8
MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells.微小RNA作为胰腺肿瘤细胞上皮-间质转化的关键调节因子
Heliyon. 2024 May 1;10(9):e30599. doi: 10.1016/j.heliyon.2024.e30599. eCollection 2024 May 15.
9
Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression.肿瘤微环境中癌干细胞与免疫细胞的相互作用促进肝癌进展
Front Med. 2024 Jun;18(3):430-445. doi: 10.1007/s11684-023-1049-z. Epub 2024 Apr 11.
10
Tumor cell stemness in gastrointestinal cancer: regulation and targeted therapy.胃肠道癌中的肿瘤细胞干性:调控与靶向治疗
Front Mol Biosci. 2024 Feb 22;10:1297611. doi: 10.3389/fmolb.2023.1297611. eCollection 2023.